Harvard Apparatus Regenerative Technology Inc. (HRGN)
OTCMKTS · Delayed Price · Currency is USD
1.400
0.00 (0.00%)
At close: Aug 14, 2026

HRGN Statistics

Total Valuation

HRGN has a market cap or net worth of 24.61 million. The enterprise value is 24.91 million.

Market Cap24.61M
Enterprise Value 24.91M

Important Dates

The next estimated earnings date is Monday, November 9, 2026.

Earnings Date Nov 9, 2026
Ex-Dividend Date n/a

Share Statistics

HRGN has 17.58 million shares outstanding. The number of shares has increased by 10.80% in one year.

Current Share Class 17.58M
Shares Outstanding 17.58M
Shares Change (YoY) +10.80%
Shares Change (QoQ) +2.30%
Owned by Insiders (%) 38.89%
Owned by Institutions (%) n/a
Float 8.63M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 25.06
PB Ratio -17.85
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 25.36
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 0.26

Current Ratio 0.26
Quick Ratio 0.12
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF -0.16
Interest Coverage -516.15

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -219.45%
Return on Invested Capital (ROIC) -3,038.95%
Return on Capital Employed (ROCE) 494.47%
Weighted Average Cost of Capital (WACC) 2.32%
Revenue Per Employee 122,750
Profits Per Employee -835,375
Employee Count8
Asset Turnover 0.51
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -4.37% in the last 52 weeks. The beta is -0.35, so HRGN's price volatility has been lower than the market average.

Beta (5Y) -0.35
52-Week Price Change -4.37%
50-Day Moving Average 1.38
200-Day Moving Average 1.72
Relative Strength Index (RSI) 58.85
Average Volume (20 Days) 3,453

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, HRGN had revenue of 982,000 and -6.68 million in losses. Loss per share was -0.39.

Revenue982,000
Gross Profit 74,000
Operating Income -6.71M
Pretax Income -6.68M
Net Income -6.68M
EBITDA -6.71M
EBIT -6.71M
Loss Per Share -0.39
Full Income Statement

Balance Sheet

The company has 351,000 in cash and 645,000 in debt, with a net cash position of -294,000 or -0.02 per share.

Cash & Cash Equivalents 351,000
Total Debt 645,000
Net Cash -294,000
Net Cash Per Share -0.02
Equity (Book Value) -1.38M
Book Value Per Share -0.08
Working Capital -2.25M
Full Balance Sheet

Cash Flow

Operating Cash Flow -4.01M
Capital Expenditures n/a
Depreciation & Amortization 4,000
Net Borrowing n/a
Free Cash Flow -4.01M
FCF Per Share -0.23
Full Cash Flow Statement

Margins

Gross Margin 7.54%
Operating Margin -683.30%
Pretax Margin -680.55%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

HRGN does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -10.80%
Shareholder Yield -10.80%
Earnings Yield -27.15%
FCF Yield -16.28%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

The last stock split was on December 22, 2017. It was a reverse split with a ratio of 0.05.

Last Split Date Dec 22, 2017
Split Type Reverse
Split Ratio 0.05

Scores

Altman Z-Score n/a
Piotroski F-Score 2